Black Friday saleUp to 70% OFF
NNN

PROVEXIS PLC LS-,001

No trades
See on Supercharts
Overview
Financials News Discussions Seasonals

NZCA chart


Full chart

Key stats


Market capitalization
‪19.07 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0005 EUR
Net income (FY)
‪−685.83 K‬ EUR
Revenue (FY)
‪938.20 K‬ EUR
Shares float
‪2.05 B‬
Beta (1Y)
−0.52

About PROVEXIS ORD GBP0.001


Sector
Health Technology
CEO
Ian Ford
Headquarters
Reading
Website
provexis.com
Founded
2004
ISIN
GB00B0923P27
FIGI
BBG000QN5HM3
Provexis Plc engages in the development and commercialization of Fruitflow, an anti-thrombotic technology. The Fruitflow is a scientifically proven tomato extract which inhibits platelet aggregation. The company was founded in 1999 and is headquartered in Reading, the United Kingdom.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

NZCA news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PROVEXIS PLC LS-,001 stocks are traded under the ticker NZCA.
NZCA reached its all-time high on Dec 13, 2010 with the price of 0.0540 EUR, and its all-time low was 0.0005 EUR and was reached on Oct 25, 2024. View more price dynamics on NZCA chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track PROVEXIS PLC LS-,001 financials in yearly and quarterly reports right on TradingView.
NZCA net income for the last half-year is ‪−373.35 K‬ EUR, while the previous report showed ‪−308.19 K‬ EUR of net income which accounts for −21.14% change. Track more PROVEXIS PLC LS-,001 financial stats to get the full picture.
No, NZCA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 29, 2024, the company has 2.00 employees. See our rating of the largest employees — is PROVEXIS PLC LS-,001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROVEXIS PLC LS-,001 EBITDA is ‪−706.13 K‬ EUR, and current EBITDA margin is −74.68%. See more stats in PROVEXIS PLC LS-,001 financial statements.
Like other stocks, NZCA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROVEXIS PLC LS-,001 stock right from TradingView charts — choose your broker and connect to your account.